08:13 AM EST, 11/04/2024 (MT Newswires) -- Enfusion ( ENFN ) reported Q3 adjusted net income Monday of $0.05 per diluted share, up from $0.04 a year earlier.

Analysts polled by Capital IQ expected $0.06.

Revenue for the quarter ended Sept. 30 was $51.2 million, up from $44.4 million a year earlier.

Analysts surveyed by Capital IQ expected $52.2 million.

For 2024, the company narrowed its revenue projection to between $202 million and $205 million, from a previous outlook of $200 million to $210 million. Analysts polled by Capital IQ expect $204.8 million.